» Articles » PMID: 21303946

Transcription Factor AP-2α Promotes EGF-dependent Invasion of Human Trophoblast

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2011 Feb 10
PMID 21303946
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The basic helix-span-helix transcription factor activating protein (AP)-2α is critically involved in cell-specific hormone expression of syncytializing human trophoblasts. Its role in invasive trophoblast differentiation, however, remains largely elusive. Using RT-PCR, Western blotting, and immunofluorescence of first-trimester placentae, we here show that AP-2α is expressed in extravillous trophoblasts (EVTs) both in situ and in vitro as well as in invasive trophoblast cell lines. Its protein expression was increased upon supplementation of epidermal growth factor (EGF) both in primary EVTs and trophoblastic SGHPL-5 cells. Gene silencing of AP-2α using small hairpin microRNA (shRNAmir) did not affect basal invasion of SGHPL-5 cells through Matrigel-coated filters but reduced EGF-stimulated invasion. Similarly, treatment of primary EVTs with AP-2α small interfering RNA decreased EGF-dependent invasion. Proliferation of SGHPL-5 cells and primary EVTs, measured by cumulative cell numbers and 5-bromo-2'-deoxyuridine labeling, respectively, were not affected on loss of AP-2α. EGF-dependent induction of matrix metalloproteinase (MMP)-2, pro- and active form of urokinase plasminogen activator, and chorionic gonadotropin (CG)-β was noticed in shRNAmir-control cells, whereas these genes were suppressed in EGF-treated shRNAmir-AP-2α cells. Similarly, EGF-stimulated MMP-2 and CGβ protein expression was reduced in AP-2α small interfering RNA-treated primary EVTs. Knockdown of AP-2α also decreased luciferase activity of the CGβ5 promoter in SGHPL-5 cells, which was compensated upon transient overexpression of AP-2α cDNA. In conclusion, we show that AP-2α expression positively affects human trophoblast invasion under EGF-stimulated conditions, likely by inducing critical invasion-promoting genes such MMP-2, urokinase plasminogen activator, and CG.

Citing Articles

A genome scale transcriptional regulatory model of the human placenta.

Paquette A, Ahuna K, Hwang Y, Pearl J, Liao H, Shannon P Sci Adv. 2024; 10(26):eadf3411.

PMID: 38941464 PMC: 11212735. DOI: 10.1126/sciadv.adf3411.


Insights into the immunomodulatory regulation of matrix metalloproteinase at the maternal-fetal interface during early pregnancy and pregnancy-related diseases.

Jing M, Chen X, Qiu H, He W, Zhou Y, Li D Front Immunol. 2023; 13:1067661.

PMID: 36700222 PMC: 9869165. DOI: 10.3389/fimmu.2022.1067661.


(Dis)similarities between the Decidual and Tumor Microenvironment.

Krstic J, Deutsch A, Fuchs J, Gauster M, Gorsek Sparovec T, Hiden U Biomedicines. 2022; 10(5).

PMID: 35625802 PMC: 9138511. DOI: 10.3390/biomedicines10051065.


A genome-wide CRISPR-Cas9 knockout screen identifies essential and growth-restricting genes in human trophoblast stem cells.

Dong C, Fu S, Karvas R, Chew B, Fischer L, Xing X Nat Commun. 2022; 13(1):2548.

PMID: 35538076 PMC: 9090837. DOI: 10.1038/s41467-022-30207-9.


In Vitro Model of Human Trophoblast in Early Placentation.

Bacenkova D, Trebunova M, Cizkova D, Hudak R, Dosedla E, Findrik-Balogova A Biomedicines. 2022; 10(4).

PMID: 35453654 PMC: 9029210. DOI: 10.3390/biomedicines10040904.